NEW YORK (GenomeWeb) – Enterome and Synthetic Biologics will conduct microbiome research on the effects of beta-lactam antibiotics on humans as part of an agreement announced today.

The deal includes a clinical microbiome study of about 100 patients anticipated to begin in July, which could aid Synthetic Biologics as it further develops SYN-004 for protecting the gut microbiome from the effects of intravenous beta-lactam antibiotics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.